Carl Zeiss Meditec AG (AFX)

Carl Zeiss Meditec AG (AFX)

Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Carl Zeiss Meditec AG (AFX) Profile

Carl Zeiss Meditec AG is a medical technology company with operations in Germany, the European Union, the United States, Asia, and elsewhere. The company is divided into two segments: ophthalmology devices and microsurgery. The Ophthalmic Devices category includes services and solutions for diagnosing and treating eye problems, as well as equipment and consumables for cataract, retinal, and refractive surgery. It offers services to ophthalmologists and optometrists in private practice, as well as physicians and surgeons in hospitals and outpatient surgical clinics. Microsurgery provides visualization solutions for minimally invasive surgical procedures, as well as solutions for ear, nose, and throat, plastic and reconstructive, dental, and spinal operations. The company is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Latest stock price 142.25-4.95 (-3.36%) At close: January 18 05:35PM CET Full Time Employees:3,531. Market cap 12.60B EUR. Subsidiaries: Carl Zeiss Meditec, Inc., Carl Zeiss Meditec SAS, Carl Zeiss Vision Hungary Optikai Korlatolt Felelossegu Tarsasag, Carl Zeiss Meditec Systems, and more.

Carl Zeiss Meditec AG (AFX.xetr)Analysis
Carl Zeiss Meditec generated sales of roughly €1,647 million in the fiscal year 2020/21 (previous year: €1,336 million), a 23.3 percent increase (adjusted for currency effects: 26.5 percent). Orders received climbed all the more dramatically to around €1,731 million (+29.1%, or +32.6 percent when currency impacts are taken into account). Earnings before interest and taxes (EBIT) climbed significantly to around €374 million (€178 million in the prior year. Margins on EBITDA were 22.7 percent (prior year: 13.3 percent.

Holding cost
Trading hours in US Eastern Time
10:00 - 18:30
10:00 - 18:30
10:00 - 18:30
10:00 - 18:30
10:00 - 18:30

Start Trading Carl Zeiss Meditec AG (AFX)
with a Market Leader Today

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.

6 Reasons to Trade Share
CFDs with FP Markets

An Australian-regulated
forex & CFD broker

Go Long or Short

Increase your ability to profit in all market conditions Leverage options up to 20:1

Direct Market Access (DMA) Execution

Real-time, transparent share prices Control, Functionality and deep liquidity Full Market depth & see your orders in the queue

Advanced Platforms
& Technology

MT4, MT5, Webtrader & Iress with superior client portal

24/5 Multilingual
Customer Support

Award winning support & personal account managers

Global Exposure

Low margins and competitive commission +10,000 products on global stocks across 4 continents

Earn Dividends

On long positions No ownership of physical shares necessary

Start Trading
in Minutes

Open an account now

bullet Access 10,000+ financial instruments
bullet Auto open & close positions
bullet News & economic calendar
bullet Technical indicators & charts
bullet Many more tools included

By supplying your email you agree to FP Markets privacy policy and receive future marketing materials from FP Markets. You can unsubscribe at any time.

Get instant Updates in Telegram
Sitemap | © FP Markets 2022